ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Onyx Pharmaceuticals, Inc.'s marketable securities for the quarter that ended in Jun. 2013 was $427.4 Mil.
Onyx Pharmaceuticals, Inc.'s quarterly marketable securities declined from Dec. 2012 ($331.2 Mil) to Mar. 2013 ($294.2 Mil) but then increased from Mar. 2013 ($294.2 Mil) to Jun. 2013 ($427.4 Mil).
Onyx Pharmaceuticals, Inc.'s annual marketable securities increased from Dec. 2010 ($323.0 Mil) to Dec. 2011 ($474.8 Mil) but then declined from Dec. 2011 ($474.8 Mil) to Dec. 2012 ($331.2 Mil).
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' marketable securities also includes "Other Short Term Investment".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data